Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects in both the mother and the fetus resulting from sys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lewis J. Renshall, Frances Beards, Angelos Evangelinos, Susan L. Greenwood, Paul Brownbill, Adam Stevens, Colin P. Sibley, John D. Aplin, Edward D. Johnstone, Tambet Teesalu, Lynda K. Harris
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
placenta
pregnancy
fetal growth restriction
liposomes
epidermal growth factor
Pharmacy and materia medica
RS1-441
Acceso en línea:https://doaj.org/article/31d09fe8761e42b3bf935d5bee54fcfc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/31d09fe8761e42b3bf935d5bee54fcfc

Ejemplares similares